Programmability
Binding, entry, lysis, and payload functions can be changed as separate engineering layers.
Innovation
Location is a therapeutic variable.
Many biologic payloads are limited not only by what they do, but by whether they can reach the cellular compartment where they need to act. SiVEC approaches intracellular access as an engineering problem.
Why intracellular delivery matters
A potent molecule cannot act on a target it never reaches.
Intracellular proteins, nucleic acids, and regulatory pathways remain difficult to address with many conventional delivery approaches. BactPac may create a different route to those targets.
Cargo breadth
The architecture is being evaluated across nucleic-acid and protein payload classes.
Spatial control
Delivery is designed around the cellular location of the intended target.
Biological manufacture
Some payloads may be produced by BactPac before or during the delivery sequence.
Scientific language
The site makes the maturity of each statement visible.
Demonstrated
Observations supported by completed experiments and suitable source records.
Engineered
Functions intentionally designed into BactPac or the payload architecture.
Predicted
Performance expected from mechanism or modeling but not yet fully demonstrated.
In development
Questions being addressed through active platform and program work.
Open development questions
What must be measured next.
01
Target-cell selectivity across relevant biological systems
02
Biodistribution, persistence, and clearance after administration
03
Payload translation, localization, stability, and functional persistence
04
Repeat-dose behavior and immune response
05
Manufacturing controls for a final therapeutic configuration